Duncan M Smith

Title: Duncan M. Smith: Innovator in Pharmaceutical Compounds

Introduction

Duncan M. Smith is a notable inventor based in Thousand Oaks, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating obesity and related conditions. With a total of two patents to his name, his work reflects a commitment to advancing medical science.

Latest Patents

Duncan's latest patents include "Substituted piperazinyl amides and methods of use" and "Substituted piperidines and methods of use." The first patent focuses on selected substituted piperazine compounds that are effective for the prophylaxis and treatment of diseases, such as obesity. This invention encompasses novel compounds, analogs, prodrugs, and pharmaceutically acceptable salts, along with pharmaceutical compositions and methods for treating conditions involving the activation of the melanocortin receptor. The second patent similarly addresses substituted piperidine compounds with the same therapeutic applications and includes processes for making these compounds and intermediates useful in such processes.

Career Highlights

Duncan M. Smith is associated with Amgen Inc., a leading biotechnology company known for its innovative approaches to medicine. His work at Amgen has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Throughout his career, Duncan has collaborated with esteemed colleagues, including Christopher Harold Fotsch